Ledger.Open graph →
SEC Form D · Amendment · filed July 16, 2018

Compass Therapeutics LLC

Offering
$170.2M
Sold
$110.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Anabatic Investment Partners, LLC · Oakbrook Terrace, ILExecAngela C. Pierce · San Antonio, TXExecMadison C. Mauze · San Antonio, TXExecWilliam C. Powell · San Antonio, TXDirectorMichael H. Lowinger · Los Angeles, CAExec · Director · PromoterTyson Halsey · CHARLESTON, SCDirectorBenjamin C. Browning · Stamford, CTDirectorJoe C. Lamantia Iii · San Antonio, TXExecAnabatic GP, LLC · Oakbrook Terrace, ILExecMicaela Kelley · London, United KingdomDirectorMichael C. Zucker · San Antonio, TXDirectorBenjamin Forman · San Francisco, CADirector · PromoterRichard Cleaver · Stamford, CTExec · Director · PromoterGeneral Partner of the General Partner Pitango GP Health Holdings Ltd · Herzliya, L3DirectorPitango H.T. Fund I, LP · Herzliya, L3DirectorWilliam G. Neisel · Dallas, TXExecDavid S. Gassko · Dallas, TXExecEdgar G. O'Brien · Edina, MNDirector · PromoterAdam G. Bernier · Edina, MNDirectorJohn C. Brengard · Plano, TXExecMatthew Ciardiello · Poplar, MTExecYusuf I. Mugaloglu · New York, NYExecKarl Heinz Horrer · Luxembourg, LuxembourgDirectorJeff B. Cook · DENVER, CODirectorTimothy J. Anderson · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗